JP2012046538A5 - - Google Patents

Download PDF

Info

Publication number
JP2012046538A5
JP2012046538A5 JP2011226655A JP2011226655A JP2012046538A5 JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5 JP 2011226655 A JP2011226655 A JP 2011226655A JP 2011226655 A JP2011226655 A JP 2011226655A JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5
Authority
JP
Japan
Prior art keywords
composition
peptide analog
seq
target muscle
promote
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011226655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012046538A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012046538A publication Critical patent/JP2012046538A/ja
Publication of JP2012046538A5 publication Critical patent/JP2012046538A5/ja
Pending legal-status Critical Current

Links

JP2011226655A 2003-01-21 2011-10-14 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 Pending JP2012046538A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44177203P 2003-01-21 2003-01-21
US60/441,772 2003-01-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010215438A Division JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Publications (2)

Publication Number Publication Date
JP2012046538A JP2012046538A (ja) 2012-03-08
JP2012046538A5 true JP2012046538A5 (https=) 2012-04-19

Family

ID=32771972

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006501057A Withdrawn JP2006516287A (ja) 2003-01-21 2004-01-21 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2010215438A Expired - Fee Related JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2011226655A Pending JP2012046538A (ja) 2003-01-21 2011-10-14 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006501057A Withdrawn JP2006516287A (ja) 2003-01-21 2004-01-21 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2010215438A Expired - Fee Related JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Country Status (9)

Country Link
US (2) US7183373B2 (https=)
EP (1) EP1587526B1 (https=)
JP (3) JP2006516287A (https=)
AT (1) ATE530191T1 (https=)
AU (1) AU2004205659B2 (https=)
CA (1) CA2506855C (https=)
DK (1) DK1587526T3 (https=)
ES (1) ES2375797T3 (https=)
WO (1) WO2004065410A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841531B2 (en) 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
EP1587526B1 (en) * 2003-01-21 2011-10-26 Genervon Biopharmaceuticals LLC Mntf peptides and compositions and methods of use
WO2007058982A2 (en) * 2005-11-10 2007-05-24 Genervon Biopharmaceuticals Llc Mntf differentiation and growth of stem cells
US8340193B2 (en) * 2006-08-04 2012-12-25 Microsoft Corporation Wyner-Ziv and wavelet video coding
WO2008057609A2 (en) * 2006-11-10 2008-05-15 Genervon Biopharmaceuticals Llc Methods of treating neuronal disorders using mntf peptides and analogs thereof
EP2000134A1 (en) * 2007-06-06 2008-12-10 Neuraxo Biopharmaceuticals GmbH Use of a substance for the improvement of pns lesions
US20090233295A1 (en) * 2008-01-29 2009-09-17 Elias Georges Trim59 directed diagnostics for neoplastic disease
CN101952306B (zh) * 2008-02-21 2014-09-10 皮护神经科学协会 Mntf肽的化妆和皮肤病制剂
US8846615B2 (en) * 2008-02-21 2014-09-30 Genervon Biopharmaceuticals, LLC MNTF peptides
WO2016210123A1 (en) 2015-06-26 2016-12-29 Genervon Biopharmaceuticals, LLC Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease
WO2022244757A1 (ja) 2021-05-18 2022-11-24 株式会社Ｌｔｔバイオファーマ 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841531B2 (en) * 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
US6309877B1 (en) * 1996-09-27 2001-10-30 Km Biotech, Inc. Polynucleotides encoding motoneuronotrophic factors
EP1587526B1 (en) * 2003-01-21 2011-10-26 Genervon Biopharmaceuticals LLC Mntf peptides and compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2012046538A5 (https=)
Jansson et al. MicroRNA and cancer
GB201206559D0 (en) Polypeptide
JP2013544090A5 (https=)
JP2014240404A5 (https=)
CN103804482B (zh) 一种抗菌肽及其应用
NZ611878A (en) Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
JP2017529849A5 (https=)
JP2014530803A5 (https=)
EP4349359A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
JP2011177189A5 (https=)
JP2016527891A5 (https=)
RU2012120772A (ru) Варианты синтетической фитазы
MX352195B (es) Genes que proporcionan resistencia al mildiú polvoroso en cucumis melo.
Pinto et al. Utilization of antimicrobial peptides, analogues and mimics in creating antimicrobial surfaces and bio-materials
NZ610620A (en) Inhibitors of apoptosis and uses thereof
JP2015533791A5 (https=)
JP2013531491A5 (https=)
JP2014532722A5 (https=)
MY169650A (en) Crystalline recombinant interferon with altered spatial configuration,three-dimensional structure and uses thereof
JP2014527801A5 (https=)
Wang et al. The versatile functions of LRR-only proteins in mollusk Chlamys farreri
RU2013126628A (ru) Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
JP2013504519A5 (https=)